BOLD

Boundless Bio (BOLD) Posts First Revenue of $17.3M, Narrows Q4 Loss to $0.58/Share

3 weeks ago

Boundless Bio narrows Q4 loss to $0.58/share and posts first-ever revenue of $17.3M, guiding to $78-80M for 2026.